STOCK TITAN

[Form 4] DaVita Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

DaVita Inc. director Adam H. Schechter reported a non-derivative acquisition of company stock on 08/15/2025. The filing shows 369 shares were acquired with a reported price of $0, leaving the reporting person with 4,699 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 08/19/2025. No derivative transactions or additional remarks are reported in the filing.

Adam H. Schechter, amministratore di DaVita Inc., ha dichiarato un acquisto non derivato di azioni della società in data 15/08/2025. La comunicazione indica l'acquisizione di 369 azioni al prezzo riportato di $0, portando la partecipazione complessiva del dichiarante a 4.699 azioni possedute in modo benefico. Il Modulo 4 è stato firmato da un procuratore il 19/08/2025. Non sono segnalate operazioni su strumenti derivati né altre osservazioni nel documento.

Adam H. Schechter, director de DaVita Inc., informó una adquisición no derivada de acciones de la compañía el 15/08/2025. La presentación muestra la adquisición de 369 acciones a un precio informado de $0, dejando al declarante con 4.699 acciones de propiedad beneficial. El Formulario 4 fue firmado por un apoderado el 19/08/2025. No se informan transacciones derivadas ni comentarios adicionales en la presentación.

DaVita Inc. 이사 Adam H. Schechter는 2025-08-15에 비파생형식의 자사 주식 취득을 신고했습니다. 제출서류에는 369주를 매수했으며 신고된 가격은 $0로, 신고자는 총 4,699주의 실질적 보유주식을 가지게 된 것으로 나와 있습니다. Form 4는 2025-08-19에 대리인이 서명했습니다. 파생상품 거래나 추가 설명은 보고되지 않았습니다.

Adam H. Schechter, administrateur de DaVita Inc., a déclaré une acquisition non dérivée d'actions de la société le 15/08/2025. Le dossier indique l'acquisition de 369 actions à un prix déclaré de 0 $, laissant la personne déclarante détentrice beneficiale de 4 699 actions. Le formulaire 4 a été signé par un mandataire le 19/08/2025. Aucune transaction dérivée ni remarque supplémentaire n'est mentionnée dans le dépôt.

Adam H. Schechter, Direktor von DaVita Inc., meldete am 15.08.2025 den nicht-derivativen Erwerb von Unternehmensaktien. Die Einreichung weist den Erwerb von 369 Aktien zu einem gemeldeten Preis von $0 aus, wodurch die berichtete wirtschaftliche Beteiligung der meldenden Person 4.699 Aktien beträgt. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten unterschrieben. In der Einreichung werden keine Derivatgeschäfte oder weitere Anmerkungen angegeben.

Positive
  • Insider acquisition reported: Director Adam H. Schechter acquired 369 shares, increasing beneficial ownership to 4,699 shares.
  • Clear, timely disclosure: The Form 4 was signed and filed, satisfying Section 16 reporting requirements.
Negative
  • None.

Insights

TL;DR: Routine insider stock grant reported; no derivatives or unusual dispositions.

The Form 4 documents a straightforward non-derivative acquisition of 369 shares by a director, increasing beneficial ownership to 4,699 shares. The $0 price suggests these shares were granted rather than purchased, though the form provides no plan or grant agreement details. This is a standard disclosure under Section 16 and does not, on its face, indicate any change in control or material shift in governance.

TL;DR: Small, routine insider share acquisition with limited market impact.

The transaction size is small relative to a public company and no derivatives were reported. The filing contains no additional financial metrics or contextual information about timing or vesting. For investors, this filing confirms insider ownership levels but does not provide material new information affecting valuation.

Adam H. Schechter, amministratore di DaVita Inc., ha dichiarato un acquisto non derivato di azioni della società in data 15/08/2025. La comunicazione indica l'acquisizione di 369 azioni al prezzo riportato di $0, portando la partecipazione complessiva del dichiarante a 4.699 azioni possedute in modo benefico. Il Modulo 4 è stato firmato da un procuratore il 19/08/2025. Non sono segnalate operazioni su strumenti derivati né altre osservazioni nel documento.

Adam H. Schechter, director de DaVita Inc., informó una adquisición no derivada de acciones de la compañía el 15/08/2025. La presentación muestra la adquisición de 369 acciones a un precio informado de $0, dejando al declarante con 4.699 acciones de propiedad beneficial. El Formulario 4 fue firmado por un apoderado el 19/08/2025. No se informan transacciones derivadas ni comentarios adicionales en la presentación.

DaVita Inc. 이사 Adam H. Schechter는 2025-08-15에 비파생형식의 자사 주식 취득을 신고했습니다. 제출서류에는 369주를 매수했으며 신고된 가격은 $0로, 신고자는 총 4,699주의 실질적 보유주식을 가지게 된 것으로 나와 있습니다. Form 4는 2025-08-19에 대리인이 서명했습니다. 파생상품 거래나 추가 설명은 보고되지 않았습니다.

Adam H. Schechter, administrateur de DaVita Inc., a déclaré une acquisition non dérivée d'actions de la société le 15/08/2025. Le dossier indique l'acquisition de 369 actions à un prix déclaré de 0 $, laissant la personne déclarante détentrice beneficiale de 4 699 actions. Le formulaire 4 a été signé par un mandataire le 19/08/2025. Aucune transaction dérivée ni remarque supplémentaire n'est mentionnée dans le dépôt.

Adam H. Schechter, Direktor von DaVita Inc., meldete am 15.08.2025 den nicht-derivativen Erwerb von Unternehmensaktien. Die Einreichung weist den Erwerb von 369 Aktien zu einem gemeldeten Preis von $0 aus, wodurch die berichtete wirtschaftliche Beteiligung der meldenden Person 4.699 Aktien beträgt. Das Formular 4 wurde am 19.08.2025 von einem Bevollmächtigten unterschrieben. In der Einreichung werden keine Derivatgeschäfte oder weitere Anmerkungen angegeben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schechter Adam H

(Last) (First) (Middle)
C/O DAVITA INC.
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/15/2025 A 369 A $0 4,699 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Stephanie N. Berberich, Attorney-in-Fact 08/19/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Adam H. Schechter report on Form 4 for DVA?

The filing reports a non-derivative acquisition of 369 shares on 08/15/2025.

How many DaVita (DVA) shares does the reporting person own after the transaction?

The reporting person beneficially owns 4,699 shares following the reported transaction.

What price was reported for the acquired shares in the DVA Form 4?

The filing reports a price of $0 for the 369 shares.

Were any derivative securities reported in this DVA Form 4?

No derivative securities were reported; Table II contains no entries.

When was the Form 4 for this DVA transaction signed?

The signature block shows the form was signed by an attorney-in-fact on 08/19/2025.
Davita Inc

NYSE:DVA

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

9.77B
35.76M
49.99%
52.46%
8.24%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER